Condition (MeSH)
Blister
ClinicalTrials.gov lists 32 trials for Blister or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
32 of the 32 trials are tagged with Blister itself; the rest are tagged with a narrower condition beneath it.
When did Blister trials start? (19)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2024 | 1 |
| 2023 | 2 |
| 2022 | 2 |
| 2021 | 1 |
| 2018 | 2 |
| 2017 | 2 |
| 2016 | 1 |
| 2015 | 2 |
Showing 10 of 19 earlier years.
No forecast is made for this condition: it averages 1.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 32 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Blister trials in? (8)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 7 |
| Phase 1/2 | 1 |
| Phase 2 | 4 |
| Phase 2/3 | 1 |
| Phase 3 | 2 |
| Phase 4 | 3 |
| Not applicable | 4 |
| Observational | 10 |
How many Blister trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Completed | 20 |
| Terminated | 1 |
| Withdrawn | 1 |
| Unknown status | 7 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Blister trials? (5)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 1 |
| AstraZeneca | 1 |
| GlaxoSmithKline | 1 |
| Janssen Research & Development, LLC | 1 |
| Johnson & Johnson Consumer and Personal Products Worldwide | 1 |
Which drugs are being tested for Blister? (8)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Endotoxin | 1 |
| PF-05180999 | 1 |
| Bertilimumab | 1 |
| Dapsone | 1 |
| PREDNISOLONE | 1 |
Showing 5 of 8 drugs.
Interventions as named in the registry (7)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Bevacizumab 1 | 2 |
| Benralizumab Arm B | 1 |
| S. aureus | 1 |
| Standard Topical Care Pathway | 1 |
| Botulinic toxin | 1 |
Showing 5 of 7 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Blister trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Pemphigoid | 5 | 1 |
| Covid-19 | 2 | 1 |
| Osteoarthritis | 2 | 1 |
| Sepsis | 2 | 1 |
| Acute respiratory failure | 1 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Blister? (123)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Mapping Bullous Emphysema With Lung Ultrasound: A Prospective Multicentre Study. | Respirology (Carlton, Vic.) | 2025 | Yes |
| Study protocol for a phase 1, randomised, double-blind, placebo-controlled study to investigate the safety, tolerability and pharmacokinetics of ascending topical doses of TCP-25 applied to epidermal suction blister wounds in healthy male and female volunteers. | BMJ open | 2023 | Yes |
| Hemoptysis and a Newly Formed Lung Bulla in a Case of Convalescent COVID-19 Pneumonia. | Internal medicine (Tokyo, Japan) | 2021 | Yes |
| Recovery of Contrast Sensitivity After Descemet Membrane Endothelial Keratoplasty. | Cornea | 2021 | Yes |
| Spontaneous pneumothorax and subpleural bullae in a patient with COVID-19: a 92-day observation. | European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery | 2020 | Yes |
Showing 5 of 123 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.